Ardsley drugmaker to pay $525 million for Civitas Therapeutics
NEW YORK – Acorda Therapeutics Inc. of Ardsley plans to buy privately held Civitas Therapeutics for $525 million in cash as the drugmaker seeks to expand into treatments for Parkinson's disease.
16:50 Sony Announces Xperia XZ Premium, With 4K Display and Snapdragon 8357
19:58 Oscars Primer: What You Need to Know Before Tonight's Ceremony22
18:13 Warren Buffett's Shareholder Letter: 5 Lessons for All Investors24
13:09 JCPenney shuttering up to 140 stores as sales weaken, more sluggish growth seen ahead18